215 related articles for article (PubMed ID: 35248197)
1. Neuroimaging approaches to cognition in Parkinson's disease.
Montaser-Kouhsari L; Young CB; Poston KL
Prog Brain Res; 2022; 269(1):257-286. PubMed ID: 35248197
[TBL] [Abstract][Full Text] [Related]
2. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
Hall JM; Lewis SJG
Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
[TBL] [Abstract][Full Text] [Related]
3. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
4. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
Nombela C; Rowe JB; Winder-Rhodes SE; Hampshire A; Owen AM; Breen DP; Duncan GW; Khoo TK; Yarnall AJ; Firbank MJ; Chinnery PF; Robbins TW; O'Brien JT; Brooks DJ; Burn DJ; ; Barker RA
Brain; 2014 Oct; 137(Pt 10):2743-58. PubMed ID: 25080285
[TBL] [Abstract][Full Text] [Related]
5. Imaging in Parkinson's Disease.
Politis M; Pagano G; Niccolini F
Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
Christopher L; Strafella AP
J Neuropsychol; 2013 Sep; 7(2):225-40. PubMed ID: 23551844
[TBL] [Abstract][Full Text] [Related]
7. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
8. The role of neuroimaging in Parkinson's disease.
Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.
Massa F; Arnaldi D; De Cesari F; Girtler N; Brugnolo A; Grazzini M; Bauckneht M; Meli R; Morbelli S; Pardini M; Sambuceti G; De Carli F; Tiraboschi P; Nobili F
Neurobiol Aging; 2019 Apr; 76():9-17. PubMed ID: 30611093
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
[TBL] [Abstract][Full Text] [Related]
11. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
[TBL] [Abstract][Full Text] [Related]
12. Functional connectivity between resting-state networks reflects decline in executive function in Parkinson's disease: A longitudinal fMRI study.
Boon LI; Hepp DH; Douw L; van Geenen N; Broeders TAA; Geurts JJG; Berendse HW; Schoonheim MM
Neuroimage Clin; 2020; 28():102468. PubMed ID: 33383608
[TBL] [Abstract][Full Text] [Related]
13. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson's disease.
Díez-Cirarda M; Ojeda N; Peña J; Cabrera-Zubizarreta A; Lucas-Jiménez O; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
Eur J Neurol; 2018 Jan; 25(1):5-12. PubMed ID: 28940855
[TBL] [Abstract][Full Text] [Related]
15. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
[TBL] [Abstract][Full Text] [Related]
16. Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis.
Wolters AF; van de Weijer SCF; Leentjens AFG; Duits AA; Jacobs HIL; Kuijf ML
Parkinsonism Relat Disord; 2019 May; 62():16-27. PubMed ID: 30580907
[TBL] [Abstract][Full Text] [Related]
17. Dynamic functional connectivity changes associated with dementia in Parkinson's disease.
Fiorenzato E; Strafella AP; Kim J; Schifano R; Weis L; Antonini A; Biundo R
Brain; 2019 Sep; 142(9):2860-2872. PubMed ID: 31280293
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging of Parkinson's disease: Expanding views.
Weingarten CP; Sundman MH; Hickey P; Chen NK
Neurosci Biobehav Rev; 2015 Dec; 59():16-52. PubMed ID: 26409344
[TBL] [Abstract][Full Text] [Related]
19. Functional MRI in Parkinson's Disease Cognitive Impairment.
Baggio HC; Junqué C
Int Rev Neurobiol; 2019; 144():29-58. PubMed ID: 30638456
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis.
Albrecht F; Ballarini T; Neumann J; Schroeter ML
Neuroimage Clin; 2019; 21():101594. PubMed ID: 30514656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
